Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

612 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; Authors/Task Force Members; Document Reviewers. Ponikowski P, et al. Among authors: van der meer p. Eur J Heart Fail. 2016 Aug;18(8):891-975. doi: 10.1002/ejhf.592. Epub 2016 May 20. Eur J Heart Fail. 2016. PMID: 27207191 Free article. No abstract available.
Erythropoietin in cardiovascular diseases.
van der Meer P, Voors AA, Lipsic E, van Gilst WH, van Veldhuisen DJ. van der Meer P, et al. Among authors: van gilst wh, van veldhuisen dj. Eur Heart J. 2004 Feb;25(4):285-91. doi: 10.1016/j.ehj.2003.11.017. Eur Heart J. 2004. PMID: 14984916 Review.
Protective effects of erythropoietin in cardiac ischemia: from bench to bedside.
Lipsic E, Schoemaker RG, van der Meer P, Voors AA, van Veldhuisen DJ, van Gilst WH. Lipsic E, et al. Among authors: van gilst wh, van der meer p, van veldhuisen dj. J Am Coll Cardiol. 2006 Dec 5;48(11):2161-7. doi: 10.1016/j.jacc.2006.08.031. Epub 2006 Nov 9. J Am Coll Cardiol. 2006. PMID: 17161240 Free article. Review.
Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization.
Westenbrink BD, Lipsic E, van der Meer P, van der Harst P, Oeseburg H, Du Marchie Sarvaas GJ, Koster J, Voors AA, van Veldhuisen DJ, van Gilst WH, Schoemaker RG. Westenbrink BD, et al. Among authors: van gilst wh, van der harst p, van der meer p, van veldhuisen dj. Eur Heart J. 2007 Aug;28(16):2018-27. doi: 10.1093/eurheartj/ehm177. Epub 2007 Jun 17. Eur Heart J. 2007. PMID: 17576662
Endogenous erythropoietin and outcome in heart failure.
Belonje AM, Voors AA, van der Meer P, van Gilst WH, Jaarsma T, van Veldhuisen DJ. Belonje AM, et al. Among authors: van gilst wh, van der meer p, van veldhuisen dj. Circulation. 2010 Jan 19;121(2):245-51. doi: 10.1161/CIRCULATIONAHA.108.844662. Epub 2010 Jan 4. Circulation. 2010. PMID: 20048213
Stem cells in heart failure.
Domian IJ, Buikema JW, de Boer RA, van der Meer P. Domian IJ, et al. Among authors: van der meer p. Eur J Heart Fail. 2010 Jul;12(7):642-4. doi: 10.1093/eurjhf/hfq105. Eur J Heart Fail. 2010. PMID: 20576832 Free article. No abstract available.
612 results